BALAXI PHARMACEUTICALS LIMITED — Important, 11-11-2025: Updates

Balaxi Pharma's board approved Q2/H1 financial results. The company will infuse up to ₹33.2 Cr (4M USD) into its Dubai subsidiary for operational and business expansion. Its first pharmaceutical formulation plant in Hyderabad has completed setup, secured a test manufacturing license, and begun initial production batches for stability studies.